A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, operating room consumables, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for various industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. It sells provides its products under ActivArmr, AlphaTec, BioClean, EDGE, ENCORE, GAMMEX, HyFlex, Kimtech, KleenGuard, MICROFLEX, MICRO-TOUCH, RINGERS, SANDEL, and TouchNTuff brands. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia.
Financial Summary
| Share Statistics | ANSLY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4,124.5 | $416.1 | 64% |
|
| Shares Out (Mil) | 142.4 | 41.6 | 70% |
|
| Institutional Ownership | 49.7% | 83.1% | 25% |
|
| Float (Mil) | 138.5 | 35.6 | 67% |
|
| Beta | 0.57 | 0.88 | 33% |
|
| Avg Daily Volume (000s) | 0 | 333 | 0% |
|
| Price Change (52-week) |
52.6% | 65.0% | 82% |
|
| Growth | ANSLY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 1.1% | 11.8% | 20% |
|
| Net Income (5yr) | (3.3%) | (5.9%) | 36% |
|
| EPS (5yr) | (5.2%) | 10.2% | 25 |
|
| Dividends (5yr) | (2.4%) | 0.0% | 73% |
|
| Cash Flow (5yr) | 15.6% | (15.6%) | 74% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ANSLY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,140 | $119 | 61% |
|
| Net Income (TTM) (Mil) | $209 | ($9) | 68% |
|
| EPS (TTM) | $1.461 | ($0.400) | 66% |
|
| Operating Cash Flow (TTM) (Mil) | $389 | ($3) | 68% |
|
| Net Cash Flow (TTM) (Mil) | $11 | $1 | 57% |
|
| Long-Term Debt (Q1) (Mil) | $684 | $22 | 62% |
|
| Enterprise Value (Q1) (Mil) | $4,335 | $371 | 60% |
|
| Valuation | ANSLY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 3.00 | na |
|
| P/E | na | 27.8 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.6 | na |
|
| Ratios | ANSLY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 41.4% | 58.5% | 52% |
|
| Net Margin | 9.7% | (6.9%) | 62% |
|
| ROA | 6.3% | (13.4%) | 77% |
|
| ROE | 10.5% | (13.6%) | 58% |
|
| Liabilities to Assets | 38.6% | 46.1% | 29% |
|
| F-Score | na | 4 | na |
|
Ansell Limited did not pass any screens on 9/2/2026.
